Form 4 for AVTR Avantor, Inc.
Accepted 2026-02-23 00:00:00 ET · period of report 2026-02-19 · accession 0001628280-26-010826 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-23 | 2026-02-19 | AVTR | Gourdier Benoit | EVP, Bioscience, Medtech | A - Grant | $0.00 | +134.4K | 370.0K | +57% | $0 |
| D | 2026-02-23 | 2026-02-20 | AVTR | Gourdier Benoit | EVP, Bioscience, Medtech | F - Tax | $9.03 | -4,160 | 365.9K | -1% | -$37.6K |
| D | 2026-02-23 | 2026-02-19 | AVTR | Gourdier Benoit | EVP, Bioscience, Medtech | A - Grant | $0.00 | +528.8K | 528.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-19 | A | A | 134,364 | $0.00 | 370,048 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-20 | F | D | 4,160 | $9.03 | 365,888 | D | — | — | |
| 3 | Derivative | Stock Options (Right to Buy) | 2026-02-19 | A | A | 528,848 | $0.00 | 528,848 | D | $11.05 · — to 2036-02-19 | 528,848 Common Stock | (F3) Reflects a grant of stock options that vest in three equal annual installments beginning on February 19, 2027. |